輸入代號或公司名稱後按 Enter
4183

福永生技

-0.30 (-2.22%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
13.201成交張數本益比1.18股價淨值比0.00%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025500年增 +10.8%
毛利率202517.4%最新一期
營業利益率2025-1.8%最新一期
每股盈餘2025-0.33年增 -145.2%
會計項目走勢20212022202320242025
銷貨收入100.0%100.0%100.0%100.0%100.0%
銷貨收入淨額100.0%100.0%100.0%100.0%100.0%
營業收入合計100.0%100.0%100.0%100.0%100.0%
銷貨成本74.9%76.8%75.4%78.7%82.6%
營業成本合計74.9%76.8%75.4%78.7%82.6%
營業毛利(毛損)25.1%23.2%24.6%21.3%17.4%
營業毛利(毛損)淨額25.1%23.2%24.6%21.3%17.4%
推銷費用3.4%3.7%3.2%3.9%3.6%
管理費用7.9%8.8%9.0%9.3%8.2%
研究發展費用6.7%6.7%7.1%7.4%6.9%
預期信用減損損失(利益)0.3%0.6%0.0%-0.4%0.5%
營業費用合計18.2%19.7%19.3%20.1%19.2%
營業利益(損失)6.9%3.5%5.3%1.2%-1.8%
利息收入0.0%0.0%0.5%0.6%0.2%
其他收入0.0%0.0%0.1%0.1%0.1%
其他利益及損失淨額-1.6%2.8%0.1%2.5%0.0%
財務成本淨額0.5%0.5%0.5%0.5%0.4%
營業外收入及支出合計-2.0%2.5%0.3%2.8%-0.1%
稅前淨利(淨損)4.9%5.9%5.6%3.9%-1.9%
所得稅費用(利益)合計1.0%0.5%1.2%0.1%-0.4%
繼續營業單位本期淨利(淨損)3.9%5.5%4.5%3.8%-1.6%
本期淨利(淨損)3.9%5.5%4.5%3.8%-1.6%
確定福利計畫之再衡量數0.0%0.1%0.0%0.1%0.0%
與不重分類之項目相關之所得稅0.0%0.0%0.0%0.0%-0.0%
不重分類至損益之項目:0.0%0.1%0.0%0.1%0.1%
其他綜合損益(淨額)0.0%0.1%0.0%0.1%0.1%
本期綜合損益總額3.9%5.6%4.5%3.9%-1.5%
基本每股盈餘0.2%0.2%0.2%0.2%-0.1%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%-0.0%
稀釋每股盈餘0.2%0.2%0.2%0.2%-0.1%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。